A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery
A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery
This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.
Inclusion Criteria:
- Patients undergoing high risk major surgery in subjects with cardiovascular disease who are at risk of AKI.
Exclusion Criteria: